Skip to main content

This stock is down 60% in CY20 so far; brokerages say it may jump up to 81% going ahead

 The steep correction in the stock price of Raymond provides the contrarian investor an opportunity to invest in a high-quality consumer franchise as the markets enter unlock phase of the pandemic.

With 'Unlock 5.0' coming into effect, consumer franchise companies such as Raymond can witness strong traction, said a report from brokerage firm LKP Securities.

LKP has initiated coverage on Raymond with a 'buy' call with a 12-month SOTP-based target price of Rs 485, which is an 81% upside from the September 28 closing price of the stock on NSE at Rs 267.65.

In the calendar year 2020 so far, the stock is down 60 percent.

The steep correction in the stock price of Raymond provides the contrarian investor an opportunity to invest in a high-quality consumer franchise as the markets enter unlock phase of the pandemic, said the brokerage.



"Our scuttlebutt approach and channel checks during the past few months on footfalls and conversion rates reinforce our conviction on the resilience of its prestigious brands," LKP said.

The cost optimisation exercise and re-calibration should help reboot Raymond and propel it to navigate the COVID crisis. Digitisation of stores, rationalisation of CAPEX and reduction in discretionary spends would

enable Raymond to emerge stronger through the COVID crisis," LKP added.

India has been relaxing coronavirus-related lockdown restrictions in a staggered manner since June under the Centre's 'Unlock' plan.

The government had allowed the reopening of metro train services as part of the 'Unlock 4.0' guidelines issued by the Ministry of Home Affairs (MHA) on August 29.

A fresh set of guidelines for easing the lockdown further are expected to come into effect for October, under what could be possibly called 'Unlock 5.0'.

This is expected to reopen up more activities outside of containment zones as the festive season is set to commence in India.

With further opening up of the economy, companies that have strong brand value and market presence will see the revival of the uptrend.

LKP Securities believes the demerger of Raymond's lifestyle business, rapid strides were taken in its real estate business along with the consolidation of its FMCG business should put to rest street apprehensions, if any, on its future-focussed strategy.

LKP underscored that the 80-acre land parcel in Thane should help Raymond execute its de-leveraging strategy going forward. Besides, the execution of its strategy on various non-core business verticals should only help hasten the recovery process going forward.

The company, reported a consolidated net loss of Rs 242.15 crore in Q1FY21, higher than the net loss of Rs 14.85 crore in the same period last year. Net sales slumped 88.6 percent year-on-year (YoY) to Rs 163.16 crore during the said quarter.

Brokerage firm Antique Stock Broking also has a buy call on Raymond with a target price of Rs 395 and said the company's operating performance was better than its expectations.

Antique said trends indicate that consumer sentiments and related spend on discretionary items are on recovery from June end.

"Tier IV/V/VI stores are performing significantly better than metros and Tier I/II/II stores. Consumer demand is back at 50 percent of Pre-COVID-19 levels in TRS (The Raymond Shop) stores and near 30-35 percent of Pre-COVID-19 levels in exclusive brand outlets," Antique said.

As per the brokerage, Raymond will continue to focus on leaner cost structure, conservation of cash and managing liquidity in FY21. The company has guided a reduction of 30-33 percent in OPEX costs for FY21.

With the festive and wedding season coming up, consumer spending is expected to improve which will bring in much-needed recovery.

Disclaimer: The views and investment tips expressed by investment experts on SD Solutions are their own and not that of the website or its management. SD Solutions advises users to check with certified experts before taking any investment decisions.

Source - Moneycontrol.com

Comments

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...

Similar to 2020, D-Street is at record high ahead of Budget 2021; will history repeat itself?

  Experts are of the view that a repeat of 2020 or what happened in March might not be possible but some consolidation cannot be ruled out. Back in March when everyone wanted to write-off 2020 from their books, hope and liquidity supported markets and investor sentiment. Nobody thought that after touching a 3-year low in March 2020, benchmark indices would give double-digit returns by the end of the year. The S&P BSE Sensex and Nifty50 rallied by about 15 percent in 2020 and the big outperformance came from the small and midcap stocks. The rally is still continuing in 2021. The S&P BSE Sensex, which climbed Mount 49K, is up over 3 percent while the Nifty50 is up over 4 percent so far in January. Sensex scaling the 49,000-mark and Nifty50 touching 14,500 levels ahead of the Budget 2021 could make anyone cautious about the strength of the rally. Back in January 2020, both Sensex and Nifty touched fresh highs ahead of Budget, and then the market fell like a pack of cards. The ...